...
首页> 外文期刊>Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association >The Glasgow Blatchford Score Is the Most Accurate Assessment of Patients With Upper Gastrointestinal Hemorrhage
【24h】

The Glasgow Blatchford Score Is the Most Accurate Assessment of Patients With Upper Gastrointestinal Hemorrhage

机译:格拉斯哥Blatchford评分是上消化道出血患者最准确的评估

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND & AIMS: Risk scoring systems are used increasingly to assess patients with upper gastrointestinal hemorrhage (UGIH). There have been comparative studies to identify the best system, but most have been retrospective and included small sample sizes, few patients with severe bleeding and with low mortality. We aimed to identify the optimal scoring system. METHODS: We performed a prospective study to compare the accuracy of the Glasgow Blatchford score (GBS), an age-extended GBS (EGBS), the Rockall score, the Baylor bleeding score, and the Cedars-Sinai Medical Center predictive index in predicting patients' (1) need for hospital-based intervention or 30-day mortality, (2) suitability for early discharge, (3) likelihood of rebleeding, and (4) mortality. We analyzed the area under receiver operating characteristic (AUROC) curve, sensitivity, specificity, and positive and negative predictive values for each system. The study included 831 consecutive patients admitted with UGIH during a 2-year period. RESULTS: The GBS and EGBS better predicted patients' need for hospital-based intervention or 30-day mortality than the other systems (AUROC, 0.93; P < .001) and were also better in identifying low-risk patients (sensitivity values, 0.27-0.38; specificity values, 0.099-1). The EGBS identified a significantly higher proportion of low-risk patients than the GBS (P = .006). None of the systems accurately predicted which patients would have rebleeding or patients' 30-day mortality, on the basis of low AUROC and specificity values. CONCLUSIONS: The GBS accurately identifies patients with UGIH most likely to need hospital-based intervention and also those best suited for outpatient care. The EGBS seems promising but must be validated externally. No scoring system seems to accurately predict patients' 30-day mortality or rebleeding.
机译:背景与目的:风险评分系统越来越多地用于评估上消化道出血(UGIH)患者。已经进行了比较研究来确定最佳系统,但是大多数都具有回顾性,包括样本量小,出血严重且死亡率低的患者很少。我们旨在确定最佳评分系统。方法:我们进行了一项前瞻性研究,比较了格拉斯哥布拉奇福德评分(GBS),年龄扩展GBS(EGBS),罗克尔评分,贝勒出血评分和Cedars-Sinai医学中心预测指标在预测患者中的准确性'(1)需要基于医院的干预或30天死亡率,(2)是否适合提早出院,(3)再出血的可能性,以及(4)死亡率。我们分析了每个系统的接收器工作特征(AUROC)曲线,灵敏度,特异性以及正负预测值下的面积。该研究包括连续2年内831例接受UGIH治疗的患者。结果:与其他系统相比,GBS和EGBS可以更好地预测患者对医院干预或30天死亡率的需求(AUROC,0.93; P <.001),并且在识别低危患者方面也更好(敏感性值,0.27) -0.38;特异性值为0.099-1)。 EGBS确定的低危患者比例明显高于GBS(P = .006)。由于低的AUROC和特异性值,没有一个系统能够准确地预测哪些患者会再出血或30天死亡率。结论:GBS能够准确识别出最有可能需要医院干预以及最适合门诊治疗的UGIH患者。 EGBS似乎很有希望,但必须在外部进行验证。似乎没有评分系统可以准确预测患者30天的死亡率或再出血。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号